HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hirshberg, B. Articles by Harlan, D. M. Search for Related Content PubMed PubMed Citation Articles by Hirshberg, B. Articles by Harlan, D. M. Social Bookmarking                What's this?

Pancreatic Islet Transplantation Using the Nonhuman Primate (Rhesus) Model Predicts That the Portal Vein Is Superior to the Celiac Artery as the Islet Infusion Site

¹ National Institute of Diabetes and Digestive and Kidney Diseases/Navy Transplantation & Autoimmunity Branch, Bethesda, Maryland
² Radiology Department, Yale University, New Haven, Connecticut
³ Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland
⁴ Radiology Department, Clinical Center, National Institutes of Health, Bethesda, Maryland

We’ve established a nonhuman primate islet allotransplant model to address questions such as whether transplanting islets into the gut’s arterial system would more safely and as effectively support long-term islet allograft survival compared with the traditional portal vein approach. We reasoned that islets make up <2% of pancreatic cell mass but consume an estimated 20% of arterial blood flow, suggesting an advantage for the arterial site. Access to the arterial system is also easier and safer than the portal system. Pancreatectomized rhesus macaques were transplanted with allogeneic islets infused into either the portal vein (n = 6) or the celiac artery (n = 4). To prevent rejection, primates were given daclizumab, tacrolimus, and rapamycin. In five of six portal vein experiments, animals achieved normoglycemia without exogenous insulin. In contrast, none of the animals given intra-arterial islets showed even transient insulin independence (P = 0.048). Two of the latter animals received a second islet transplant, this time to the portal system, and both achieved insulin independence. Thus, intraportal islet transplantation under conventional immunosuppression is feasible in primates and can result in long-term insulin independence when adequate immunosuppression is maintained. Arterial islet injection, however, does not appear to be a viable islet transplantation technique.

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				M. Brissova, M. J. Fowler, W. E. Nicholson, A. Chu, B. Hirshberg, D. M. Harlan, and A. C. Powers Assessment of Human Pancreatic Islet Architecture and Composition by Laser Scanning Confocal Microscopy J. Histochem. Cytochem., September 1, 2005; 53(9): 1087 - 1097. [Abstract] [Full Text] [PDF]

				R. J. T. Owen, E. A. Ryan, K. O'Kelly, J. R. T. Lakey, M. C. McCarthy, B. W. Paty, D. L. Bigam, N. M. Kneteman, G. S. Korbutt, R. V. Rajotte, et al. Percutaneous Transhepatic Pancreatic Islet Cell Transplantation in Type 1 Diabetes Mellitus: Radiologic Aspects Radiology, October 1, 2003; 229(1): 165 - 170. [Abstract] [Full Text] [PDF]

				B. Hirshberg, S. Mog, N. Patterson, J. Leconte, and D. M. Harlan Histopathological Study of Intrahepatic Islets Transplanted in the Nonhuman Primate Model Using Edmonton Protocol Immunosuppression J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5424 - 5429. [Abstract] [Full Text] [PDF]